Biomedical subjects
C H Cunningham
Publications and source records attributed to C H Cunningham.
Avian infectious bronchitis vaccine: primordial or derived virus?
Vaccine formulations of virulent, modified/attenuated, or inactivated mono- or multivalent types of chicken embryo-propagated avian infectious bronchitis virus (IBV) at different passage levels and administered by non-parenteral routes have been used for immunization of chickens against the disease. Two doses of vaccines are generally used: 1) high level virus of lessened virulence, antigenicity and immunogenicity as "derived" from its parental virus via serial passage in and selective adaptation to the chicken embryo, and 2) low passage level virus with the above properties more closely related to the greater potency of the "primordial" parental virus in nature. The efficacy of vaccines with contemporary or candidate virus has been interpreted from a variety of criteria among which are: 1) clinical response, residence and dissemination of virus, 2) in vivo and in vitro local tissue response of tracheal epithelium, 3) protection against virulent homologous or heterologous types of IBV, and 4) induced secretory and humoral antibody. Vaccines have been economically useful and of epizootiological value but the greatest difficulty is the uncertainty of protection because of the changing antigenic, immunogenic and other properties of existing virus and of newly emerging types. With a complex virus such as IBV, the opportunities for natural selection and evolution of new or modified antigens via association with antibody of immune or of partially immune hosts are as enormous as antigenic lability resulting from fragmentation of the primordial genome under natural and/or artificial environmental stress. The present day IBV might be progeny from a unique pool of primordial genome via mutation and host-induced variation, or even persistence of primordial virus as an infinitesimal portion of the population.
Avian infectious bronchitis: characteristics of the virus and antigenic types.
Explore the source record for details and available documents.
Immunity to avian infectious bronchitis.
Avian infectious bronchitis is recognized clinically as a respiratory disease in its only natural host,the chicken, but the virus is disseminated throughout other systems by a viraemia with localization especially in the kidney and oviduct. The sensitivity or instability of the antigenic and immunogenic properties of the virus under laboratory stress or natural influences complicates the selection of seed virus for vaccines. Modified or attenuated active virus vaccines induce greater protection against subsequent infection than do inactive virus vaccines. Maternal antibody is effective in providing passive immunity for about two weeks after the chick is hatched. Immunoglobulins induced by primary infection or by vaccination are IgG effective for neutralization of virus by circulating antibody, and presumably secretory IgA in the respiratory tract, with the latter being more effective as evidenced by protection of the trachea against reinfection. The level of humoral antibody is not necessarily correlative with immunity based on chicken protection tests against challenge with virulent virus. A true carrier status apparently does not result from primary infection but it has been suggested that the chicken may possibly become an immune carrier.
Replication of avian infectious bronchitis virus in African green monkey kidney cell line VERO.
Explore the source record for details and available documents.
Responses of cell cultures from various avian species to Marek's disease virus and herpesvirus of turkeys.
Explore the source record for details and available documents.
Antibody-neutralized avian infectious bronchitis virus in chicken embryo kidney cells: entry and degradation.
Explore the source record for details and available documents.
Neutralizing antibody complex of infectious bronchitis virus.
Explore the source record for details and available documents.
Replication and cytopathogenicity of avian infectious bronchitis virus in chicken embryo kidney cells.
Explore the source record for details and available documents.
Morphogenosis of avian infectious bronchitis virus in chicken embryo fibroblasts.
Explore the source record for details and available documents.
Antigenic characterization of infectious bronchitis virus.
Explore the source record for details and available documents.
Genetic differences among chicken embryos in response to inoculation with an isolate of infectious bronchitis virus.
Explore the source record for details and available documents.
Differentiation of avian infectious bronchitis virus isolates by thermal sensitivity.
Six isolates of avian infectious bronchitis virus (IBV) at different passage levels in the chicken embryo were tested for sensitivity at 56 C, with the following results: 1) isolates differed in thermal sensitivity; 2) virus was inactivated in a first-order exponential-kinetics 2-component fashion indicative of a heterogeneous population with a preponderance, 98% or more, of thermal-sensitive (S) virions over thermal-resistant (R) virons; 3) R virions 2-component populations were inactivated; 4) recovered R virions could be maintained in continuous passage in the chicken embryo as a one-component population by the limiting-dilution technique, although there was a progressive parallel increase in thermal sensitivity associated directly with the continuous passage; 5) growth curves of isolated one-component populations of R virions were quantitatively and in time sequence similar to curves of 2-component populations of continuous-passage virus.
Immunologic methods in avian research: neutralization test.
Explore the source record for details and available documents.
Immunofluorescence of avian infectious bronchitis virus and Newcastle disease virus in singly and dually infected cell cultures.
Explore the source record for details and available documents.